Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Digestive Diseases and Sciences|March 20, 2010
Increased prevalence of reduced estimated glomerular filtration rate in chronic hepatitis C patientsSorin A Petre, Mankanwal S Sachdev, Brie N Noble, et al.
Digestive Diseases and Sciences|March 3, 2004
Hepatitis C virus recurrence in living donor liver transplant recipientsHector Rodriguez-Luna, Hugo E Vargas, Pratima Sharma, et al.
Hepatology (Baltimore, Md.)|October 24, 2002
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis CA Obaid Shakil, Brendon McGuire, Jeff Crippin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 3, 2004
Liver transplantation for hepatocellular carcinoma: the MELD impactPratima Sharma, Vijayan Balan, Jose L Hernandez, et al.
Digestive Diseases and Sciences|July 26, 2006
Liver transplantation in the MELD era: a single-center experienceMankanwal Sachdev, Jose L Hernandez, Pratima Sharma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2006
Global transcriptional effects of PEG-IFN-alpha and ribavirin on peripheral blood cells obtained from patients with chronic hepatitis CVijayan Balan, L Aravind, Diane E Grill, et al.
Digestive Diseases and Sciences|March 3, 2004
Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?Pratima Sharma, Vijayan Balan, Jose Hernandez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 20, 2003
Outcome of liver transplantation for familial amyloidotic polyneuropathyPratima Sharma, Roman E Perri, Joseph E Sirven, et al.
The American Journal of Gastroenterology|January 26, 2005
Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirinVijayan Balan, David Schwartz, George Y Wu, et al.
Pageof 4